Latest Articles
Diagnostic challenge: functional non-communicating rudimentary horn with ovarian endometriosis and ipsilateral renal agenesis.
Published: Feb. 18, 2026, midnight
Synergistic RU486 and olaparib therapy enhances apoptosis in endometriosis by simultaneously targeting hormonal signalling and DNA repair.
Endometriosis is a chronic, hormone-dependent disorder characterized by ectopic implantation of endometrial tissue, often accompanied by pain and infertility. Although the progesterone receptor modulator RU486 is effective for pain relief, …
Published: Feb. 18, 2026, midnight
Risk factors and prediction models for pain after endometriosis-related surgery-what do we (not) know yet.
Published: Feb. 18, 2026, midnight
Correction: Diagnostic accuracy of machine learning for endometriosis: a systematic review and meta-analysis.
[This corrects the article DOI: 10.3389/fendo.2025.1735567.].
Published: Feb. 18, 2026, midnight
School Nurses Are Being Trained to Detect Endometriosis in Teens — And It’s Helping - Nurse.org
School Nurses Are Being Trained to Detect Endometriosis in Teens — And It’s Helping Nurse.org
Published: Feb. 17, 2026, 6:32 p.m.
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues
Published: Feb. 17, 2026, 3:15 p.m.
Endometriosis Drug Market to Reach US$1,807.78M by 2031 at 10.4% - openPR.com
Endometriosis Drug Market to Reach US$1,807.78M by 2031 at 10.4% openPR.com
Published: Feb. 17, 2026, 9:36 a.m.
Endometriosis: Search continues for key staff for Cork regional centre - Irish Examiner
Endometriosis: Search continues for key staff for Cork regional centre Irish Examiner
Published: Feb. 17, 2026, 1:05 a.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Published: Feb. 17, 2026, 12:15 a.m.
Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis.
[This corrects the article DOI: 10.1371/journal.pone.0057724.].
Published: Feb. 17, 2026, midnight
Link copied to clipboard!